Abstract Background Statins are effective for primary prevention of cardiovascular (CV) disease, the leading cause of death in the world. Multinational guidelines emphasize CV risk as an important factor for optimal statin prescribing. However, it’s not clear how primary care providers (PCPs) use this information. The objective of this study was to determine how primary care providers use information about global CV risk for primary prevention of CV disease. Methods A double-blinded, randomized experiment using clinical vignettes mailed to office-based PCPs in the United States who were identified through the American Medical Associa...
Introduction: Risk thresholds for using statins to prevent cardiovascular disease (CVD) have recentl...
During routine yearly physicals, primary care providers often evaluate serum laboratory lipid levels...
During routine yearly physicals, primary care providers often evaluate serum laboratory lipid levels...
OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high car...
Introduction: Statin therapy is a well established treatment for hyperlipidemia. However, little is ...
Introduction: Statin therapy is a well established treatment for hyperlipidemia. However, little is ...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Recommendations for statin use for primary prevention of coronary heart disease (CHD) are based on e...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Objectives: Estimate the effect of statin prescription on mortality in the population of England and...
Background: Statin prescribing should be based on cardiovascular disease (CVD) risk, but evidence su...
Background: Statin prescribing should be based on cardiovascular disease (CVD) risk, but evidence su...
Background: Small trials with short term follow up suggest pharmacists’ interventions targeted at...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States an...
Introduction: Risk thresholds for using statins to prevent cardiovascular disease (CVD) have recentl...
During routine yearly physicals, primary care providers often evaluate serum laboratory lipid levels...
During routine yearly physicals, primary care providers often evaluate serum laboratory lipid levels...
OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high car...
Introduction: Statin therapy is a well established treatment for hyperlipidemia. However, little is ...
Introduction: Statin therapy is a well established treatment for hyperlipidemia. However, little is ...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Recommendations for statin use for primary prevention of coronary heart disease (CHD) are based on e...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Atherosclerotic plaques can form in the blood vessels from particles of cholesterol. These plaques a...
Objectives: Estimate the effect of statin prescription on mortality in the population of England and...
Background: Statin prescribing should be based on cardiovascular disease (CVD) risk, but evidence su...
Background: Statin prescribing should be based on cardiovascular disease (CVD) risk, but evidence su...
Background: Small trials with short term follow up suggest pharmacists’ interventions targeted at...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States an...
Introduction: Risk thresholds for using statins to prevent cardiovascular disease (CVD) have recentl...
During routine yearly physicals, primary care providers often evaluate serum laboratory lipid levels...
During routine yearly physicals, primary care providers often evaluate serum laboratory lipid levels...